CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01590589
NCT01590589N/ACompleted

REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)

European Huntington's Disease Network·observational·Posted May 3, 2012·Updated Sep 15, 2017

In Brief

An observational study for Huntington Disease and Huntington's Disease. Completed, enrolled 10,000 participants across 140 sites in 17 countries.

Detailed Summary

This is a multi-centre, multi-national, prospective, observational study of Huntington's disease (HD) with a control group of volunteers to: * obtain natural history data on many HD mutation carriers and individuals who are part of an HD family * relate phenotypical characteristics (genetic modifiers / wet and dry biomarkers) * expedite identification and recruitment of participants for clinical trials * develop and validate sensitive and reliable outcome measures for detecting onset and change over the natural course of premanifest and manifest HD which may also be potential outcome measures for use in future clinical trials and clinical care * plan for future research studies

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, Czechia, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 3, 2012
Enrollment StartJun 1, 2004
Primary CompletionJun 30, 2017
TodayJul 2, 2026
Enrollment to primary: 13.1 yearsPosted 14.2 years ago